GC Reiber VivoMega has announced that the company attained Sedex Members Ethical Trade Audit (SMETA) certification.
GC Reiber VivoMega (Kristiansund, Norway) has announced that the company attained Sedex Members Ethical Trade Audit (SMETA) certification. The company explains that the certification solidifies its commitment to sustainability, the promotion of responsible sourcing, reduction of environmental impacts, and the improvement of labor conditions. The certification also supports several United Nations Sustainable Development Goals.
“We are thrilled to have achieved SMETA certification,” says Snorre Glaerum Strand, CEO at GC Rieber VivoMega, in a press release. “This milestone reinforces our ongoing commitment to sustainability and responsible practices.”
The company also points out that by undergoing rigorous audits and assessments of its supply chain, the certification demonstrates its commitment to transparency and promotes more effective collaboration with its customers.
"By aligning our practices with SMETA's sustainability objectives, we can build stronger partnerships based on shared values. We can work together to develop innovative solutions and drive positive change within the omega-3 industry," explains Strand.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.